Related Experiment Video
Updated: Jul 3, 2026

Microfluidic Assay for the Assessment of Leukocyte Adhesion to Human Induced Pluripotent Stem Cell-derived Endothelial Cells (hiPSC-ECs)
Published on: November 26, 2018
Shc coordinates signals from intercellular junctions and integrins to regulate flow-induced inflammation.
Yunhao Liu1, Daniel Timothy Sweet, Mohamad Irani-Tehrani
1Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
The adaptor protein Shc plays a key role in atherosclerosis by integrating signals from blood flow to promote inflammation. Its activation in arteries correlates with disease severity, highlighting its potential as a therapeutic target.
Area of Science:
- Cardiovascular Biology
- Molecular Mechanisms of Disease
- Mechanotransduction
Background:
- Atherosclerosis is linked to chronic inflammation in blood vessels, driven by disturbed blood flow patterns.
- Endothelial cells respond to flow via mechanotransduction, but the integration of these pathways is unclear.
- The adaptor protein Shc's role in flow-induced endothelial responses is not well understood.
Purpose of the Study:
- To investigate the role of the adaptor protein Shc in endothelial response to disturbed blood flow.
- To elucidate the signaling pathways and adhesion molecules involved in Shc activation by flow.
- To determine Shc's contribution to flow-induced inflammatory signaling and atherogenesis.
Main Methods:
- Investigated Shc activation and association with cell adhesions (VE-cadherin, integrins) in endothelial cells under flow conditions.
- Utilized tyrosine kinase inhibitors (VEGFR2, Src) to study Shc activation requirements.
- Employed Shc silencing to assess its impact on signaling pathways (NF-κB) and matrix-dependent/independent signals.
- Examined Shc activation in atherosclerotic mouse arteries in vivo.
Main Results:
- Flow activates the adaptor protein Shc, which associates with cell-cell (VE-cadherin) and cell-matrix adhesions.
- Shc activation depends on VEGFR2 and Src tyrosine kinases and is partly matrix-independent.
- Shc silencing reduces both matrix-dependent and independent signals and inhibits flow-induced NF-κB activation.
- In vivo, Shc is activated in atherosclerosis-prone arterial regions, correlating with disease presence.
Conclusions:
- Shc acts as a crucial integrator of signals from cell-cell and cell-matrix adhesions in response to blood flow.
- Shc orchestrates flow-induced inflammatory signaling pathways, including NF-κB, contributing to atherogenesis.
- Targeting Shc may offer a novel therapeutic strategy for atherosclerosis by modulating vascular inflammation.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Overview of Cell-Matrix Interactions
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
What is Cell Signaling?

